TP53 loss-of-function causes vulnerability to autophagy inhibition in aggressive prostate cancer. Zhang Y, Song XL, Yu B, Foong LC, et al. Int J Urol 2022 Aug 17. doi: 10.1111/iju.15021.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang Y, Song XL, Yu B, Foong LC, et al. TP53 loss-of-function causes vulnerability to autophagy inhibition in aggressive prostate cancer. Int J Urol 2022 Aug 17. doi: 10.1111/iju.15021.
PMID: 35975690